{"title":"COVID-19 大流行对肺移植患者和罕见肺病患者队列的影响：一项单中心研究","authors":"Moustapha Hussein , Floriane Gallais , Tristan Dégot , Sandrine Hirschi , Justine Leroux , Marianne Riou , Julien Stauder , Pierre-Emmanuel Falcoz , Anne Olland , Romain Kessler , Benjamin Renaud-Picard","doi":"10.1016/j.resmer.2024.101100","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Due to the COVID-19 pandemic, France underwent several lockdown periods during 2020. Our aim was to evaluate its clinical and social impact on lung transplant (LT) patients treated at Strasbourg University Hospital, by comparing three periods: first lockdown (T1: March-May 2020), end of the first lockdown (T2: May-October 2020), and second lockdown (T3: November-December 2020) and the incidence of COVID-19 infections. A cohort of patients with rare lung disease (RLD) was also studied during T2.</p></div><div><h3>Methods</h3><p>We used clinical and paraclinical data collected during routine follow-up. A questionnaire was submitted to each patient at each period to assess their lifestyle, adherence to protective measures against COVID-19, contacts with their family and friends, and contagion risk. The incidence of new COVID-19 cases was also assessed.</p></div><div><h3>Results</h3><p>Overall, 283 LT and 57 RLD patients were included. We observed only eight COVID-19 cases over the three periods (<em>n</em> = 4 during T1, <em>n</em> = 0 during T2, and <em>n</em> = 4 during T3) in LT patients, with 37.5 % of patients hospitalized, no ICU transfers, and 100 % favorable outcomes. No case of COVID-19 was diagnosed in the RLD cohort. When comparing the three periods in the LT group, fewer patients limited their out-of-home activities during T2 (<em>p</em> < 0.0001). The frequency of these activities increased after the first lockdown, for the purchase of basic necessities (<em>p</em> < 0.0001), and professional activity continued (<em>p</em> = 0.008). We observed a significant increase in unscheduled medical consultations and in the prescription of anti-infective treatments during the end of the lockdown (<em>p</em> = 0.0002 and <em>p</em> = 0.005, respectively). Adherence to lockdown and to protective measures was high in both groups of patients.</p></div><div><h3>Conclusion</h3><p>COVID-19 incidence remained low in both groups and there were significant lifestyle evolutions in LT patients and in those with RLD between first and second lockdown.</p></div>","PeriodicalId":48479,"journal":{"name":"Respiratory Medicine and Research","volume":"85 ","pages":"Article 101100"},"PeriodicalIF":2.2000,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590041224000163/pdfft?md5=b7670dca16a55a3ee43e3ebdeb89c24b&pid=1-s2.0-S2590041224000163-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Impact of the COVID-19 pandemic on lung transplant patients and on a cohort of patients with rare lung disease: A single-center study\",\"authors\":\"Moustapha Hussein , Floriane Gallais , Tristan Dégot , Sandrine Hirschi , Justine Leroux , Marianne Riou , Julien Stauder , Pierre-Emmanuel Falcoz , Anne Olland , Romain Kessler , Benjamin Renaud-Picard\",\"doi\":\"10.1016/j.resmer.2024.101100\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Due to the COVID-19 pandemic, France underwent several lockdown periods during 2020. Our aim was to evaluate its clinical and social impact on lung transplant (LT) patients treated at Strasbourg University Hospital, by comparing three periods: first lockdown (T1: March-May 2020), end of the first lockdown (T2: May-October 2020), and second lockdown (T3: November-December 2020) and the incidence of COVID-19 infections. A cohort of patients with rare lung disease (RLD) was also studied during T2.</p></div><div><h3>Methods</h3><p>We used clinical and paraclinical data collected during routine follow-up. A questionnaire was submitted to each patient at each period to assess their lifestyle, adherence to protective measures against COVID-19, contacts with their family and friends, and contagion risk. The incidence of new COVID-19 cases was also assessed.</p></div><div><h3>Results</h3><p>Overall, 283 LT and 57 RLD patients were included. We observed only eight COVID-19 cases over the three periods (<em>n</em> = 4 during T1, <em>n</em> = 0 during T2, and <em>n</em> = 4 during T3) in LT patients, with 37.5 % of patients hospitalized, no ICU transfers, and 100 % favorable outcomes. No case of COVID-19 was diagnosed in the RLD cohort. When comparing the three periods in the LT group, fewer patients limited their out-of-home activities during T2 (<em>p</em> < 0.0001). The frequency of these activities increased after the first lockdown, for the purchase of basic necessities (<em>p</em> < 0.0001), and professional activity continued (<em>p</em> = 0.008). We observed a significant increase in unscheduled medical consultations and in the prescription of anti-infective treatments during the end of the lockdown (<em>p</em> = 0.0002 and <em>p</em> = 0.005, respectively). Adherence to lockdown and to protective measures was high in both groups of patients.</p></div><div><h3>Conclusion</h3><p>COVID-19 incidence remained low in both groups and there were significant lifestyle evolutions in LT patients and in those with RLD between first and second lockdown.</p></div>\",\"PeriodicalId\":48479,\"journal\":{\"name\":\"Respiratory Medicine and Research\",\"volume\":\"85 \",\"pages\":\"Article 101100\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-03-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2590041224000163/pdfft?md5=b7670dca16a55a3ee43e3ebdeb89c24b&pid=1-s2.0-S2590041224000163-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory Medicine and Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590041224000163\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Medicine and Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590041224000163","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
Impact of the COVID-19 pandemic on lung transplant patients and on a cohort of patients with rare lung disease: A single-center study
Introduction
Due to the COVID-19 pandemic, France underwent several lockdown periods during 2020. Our aim was to evaluate its clinical and social impact on lung transplant (LT) patients treated at Strasbourg University Hospital, by comparing three periods: first lockdown (T1: March-May 2020), end of the first lockdown (T2: May-October 2020), and second lockdown (T3: November-December 2020) and the incidence of COVID-19 infections. A cohort of patients with rare lung disease (RLD) was also studied during T2.
Methods
We used clinical and paraclinical data collected during routine follow-up. A questionnaire was submitted to each patient at each period to assess their lifestyle, adherence to protective measures against COVID-19, contacts with their family and friends, and contagion risk. The incidence of new COVID-19 cases was also assessed.
Results
Overall, 283 LT and 57 RLD patients were included. We observed only eight COVID-19 cases over the three periods (n = 4 during T1, n = 0 during T2, and n = 4 during T3) in LT patients, with 37.5 % of patients hospitalized, no ICU transfers, and 100 % favorable outcomes. No case of COVID-19 was diagnosed in the RLD cohort. When comparing the three periods in the LT group, fewer patients limited their out-of-home activities during T2 (p < 0.0001). The frequency of these activities increased after the first lockdown, for the purchase of basic necessities (p < 0.0001), and professional activity continued (p = 0.008). We observed a significant increase in unscheduled medical consultations and in the prescription of anti-infective treatments during the end of the lockdown (p = 0.0002 and p = 0.005, respectively). Adherence to lockdown and to protective measures was high in both groups of patients.
Conclusion
COVID-19 incidence remained low in both groups and there were significant lifestyle evolutions in LT patients and in those with RLD between first and second lockdown.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
